DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Judson I. Verweij J. Gelderblom H. et al.
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Lancet Oncol 2014;
15: 415-423
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.